intranuclear CRISPR delivery

Cytosurge is a Zurich, Switzerland-based company (est. 2009) that develops FluidFM technology, combining a hollow AFM cantilever, microfluidic channel, and force feedback to manipulate single living cells with nanoscale precision. It provides the FluidFM OMNIUM platform and services including Causal Insights (Live-seq same-cell molecular profiling) and CellEDIT (intranuclear CRISPR genome engineering). Its products and services are for research and development purposes only.

Read more

bioprinting/nanoprintingforce spectroscopygenome engineeringLive-seq samplingnano-injectionpick and placesingle-cell adhesion measurementsingle-cell isolation